Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T72038 | Target Info | |||
Target Name | Galectin-3 (LGALS3) | ||||
Synonyms | Mac-2 antigen; MAC2; Lectin L-29; Laminin-binding protein; L-31; IgE-binding protein; Galactoside-binding protein; Galactose-specific lectin 3; Gal-3; GALBP; Carbohydrate-binding protein 35; Carbohydrate binding protein 35; CBP 35; Beta-galactoside-binding protein LGALS3; 35 kDa lectin | ||||
Target Type | Clinical trial Target | ||||
Gene Name | LGALS3 | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | methyl 2-O-(4-fluoro-2-nitrobenzoyl)-3-O-(4-methylbenzoyl)-beta-D-talopyranoside | Ligand Info | |||
Canonical SMILES | CC1=CC=C(C=C1)C(=O)OC2C(C(OC(C2OC(=O)C3=C(C=C(C=C3)F)[N+](=O)[O-])OC)CO)O | ||||
InChI | 1S/C22H22FNO10/c1-11-3-5-12(6-4-11)20(27)33-18-17(26)16(10-25)32-22(31-2)19(18)34-21(28)14-8-7-13(23)9-15(14)24(29)30/h3-9,16-19,22,25-26H,10H2,1-2H3/t16-,17+,18+,19+,22-/m1/s1 | ||||
InChIKey | UAZQKBXLYFSZPW-NOYKIMNZSA-N | ||||
PubChem Compound ID | 164513433 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 7RH4 Co-crystallization of human galectin-3 CRD complex with Methyl 2-O-(2-nitro-4-fluoro)-benzoyl-3-O-toluoyl-b-D-talopyranoside | ||||||
Method | X-ray diffraction | Resolution | 1.20 Å | Mutation | No | [1] |
PDB Sequence |
MLIVPYNLPL
122 PGGVVPRMLI132 TILGTVKPNA142 NRIALDFQRG152 NDVAFHFNPR162 FNENNRRVIV 172 CNTKLDNNWG182 REERQSVFPF192 ESGKPFKIQV202 LVEPDHFKVA212 VNDAHLLQYN 222 HRVKKLNEIS232 KLGISGDIDL242 TSASYTMI
|
|||||
|
||||||
PDB ID: 7RGZ Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(2-nitro-4-fluoro)-benzoyl-3-O-toluoyl-b-D-talopyranoside | ||||||
Method | X-ray diffraction | Resolution | 1.49 Å | Mutation | No | [1] |
PDB Sequence |
MLIVPYNLPL
122 PGGVVPRMLI132 TILGTVKPNA142 NRIALDFQRG152 NDVAFHFNPR162 FNENNRRVIV 172 CNTKLDNNWG182 REERQSVFPF192 ESGKPFKIQV202 LVEPDHFKVA212 VNDAHLLQYN 222 HRVKKLNEIS232 KLGISGDIDL242 TSASYTMI
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia. J Med Chem. 2022 Apr 28;65(8):5975-5989. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.